PLUXEE

Pluxee reported third-quarter 2026 revenue of €312m, well above the analyst consensus of €299m and the most optimistic individual forecast of €306m. Organic revenue fell 3.3%, but was better than expected (-4.3%). Effects of the PAT reform in Brazil were smaller than feared, and the company confirmed its full-year targets (stable comparable revenues and a slight organic increase in the recurring EBITDA margin). As a result, the share price rose by around 6% and reached €12.64 intraday. » Plus sur de.investing.com

Pluxee reports total revenue of €308m for Q1 2026 and organic revenue growth of 9%, driven by the employee-benefits segment. The company confirmed its full-year targets but presented them in two scenarios, as the PAT reform in Brazil could cause revenue declines in Brazil of up to 40% in H2 2026 and up to 50% by 2027. Pluxee is responding with operational measures, renegotiations, legal steps and the introduction of open-loop solutions, and is continuing its M&A strategy (acquisitions of Skipr, ProEves) as well as securing major contracts in Italy and Mexico. The share price rose 6.19% to €13.73 after the results were published. » Plus sur de.investing.com

Pluxee recorded revenue of €308m in Q1 2026 and organic growth of 9%; operating revenue rose to €268m (+9.1%). The stock jumped 6.19% premarket to €13.73 after the figures. Strategic acquisitions and regional tenders contributed to the growth, and management confirmed the 2026 financial targets with a goal of a higher EBITDA margin and 80% cash conversion. However, risks were noted, in particular an expected revenue decline in Brazil of around 40% in H2 2026 (up to 50% by 2027) and possible delays on contracts in Romania. » Plus sur de.investing.com

Pluxee has lowered its financial targets for 2026 and now expects stable like‑for‑like revenue instead of the previously planned high single‑digit organic growth. The expected improvement in the recurring EBITDA margin has been significantly reduced, and the average recurring cash‑conversion rate for 2024–2026 is around 80%. The move follows announced reforms to Brazil’s Workers’ Food Program introducing commission caps, shorter reimbursement deadlines and voucher interoperability; Pluxee expects headwinds from mid fiscal 2026 through H1 2027 and a return to profitable growth from H2 2027. The company is considering legal action and bases its outlook on worst‑case assumptions given substantial implementation uncertainties. » Plus sur de.investing.com

Pluxee reported significant potential impacts from planned reforms to Brazil’s PAT system, after which the share plunged about 11%. The company is reviewing financial consequences and possible countermeasures and said it may pursue legal action alone or together with ABBT. Analysts see heavy burdens: Morgan Stanley estimates an EBITDA risk of up to 30% and a potential EPS hit of about 35% if the assumptions hold true. » Plus sur de.investing.com